Tenon Medical, Inc. (TNON) Stock Score, Valuation & Financial Research
Tenon Medical, Inc. is in the Healthcare sector and Medical - Devices industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 35/100.
Quick answer for TNON
Tenon Medical, Inc. currently has a Wall Street Score of 35/100. The stored market price is $5.56. Its financial score is 45/100. Its valuation score is 0/100. The latest WSS change is +2.2 points. These figures are a research snapshot, not a buy or sell recommendation.
What Tenon Medical, Inc. does
Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along its longitudinal axis. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.
TNON financial snapshot
- Wall Street Score:
- 35/100
- Current price:
- $5.56
- Market capitalization:
- $2.8M
- Revenue:
- $5.3M
- Net income:
- $-13.7M
- Free cash flow:
- $-11.0M
- Cash:
- $1.7M
- Total debt:
- $5.7M
- EPS:
- -46.30
- Financial score:
- 45/100
- Valuation score:
- 0/100
- Revenue score:
- 51/100
What stands out
- Reported year-over-year revenue growth is +0.4%.
- Free cash flow is $-11.0M, showing cash burn in the current stored period.
- The balance sheet shows $1.7M of cash versus $5.7M of total debt, so leverage deserves attention.
- The latest Wall Street Score change is +2.2 points: TNON increased 2.2 points because Revenue improved by 2.5 points, Management improved by 20 points, Buffett improved by 3.3 points.
- The current research record carries a share basis reconciled warning, which should be reviewed alongside the score.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 45/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-13.
How to research TNON
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.